Skip to contentClarengateINTELLIGENCE
Companies/09444997

Revivocell Limited

Research and experimental development on biotechnology · Warrington

ActiveUnited KingdomIncorporated 2015Private Limited Company
Register Ask analyst

Financial position

Accounts to 2025-02-28 · GBP · Company accounts

Net assets
−£245,867
Cash
—
Turnover
—
Profit / loss
—
Current assets
£66,859
Creditors < 1 year
£290,789
Equity
−£245,867
Average employees
4

Balance-sheet trend

GBP · company

Financial statements

Selected figures from the best-ranked available filing for each period. Missing values remain unknown.

10 periods
Reported figures2025-02-28Company2024-02-29Company2023-02-282022-02-282021-02-282020-02-282019-02-282018-02-282017-02-282016-02-29
Balance sheet
Net assets−£245,867−£238,129−£239,911−£142,733−£146,180−£146,903————
Equity−£245,867−£238,129−£239,911−£142,733−£146,180−£146,903−£63,748−£46,790−£17,741−£7,473
Assets
Fixed assets£1,580£2,074£2,732£2,310£1,155£0————
Current assets£66,859£55,190£31,538£21,551£35,993£13,714£26,484£15,461£9,402£36,518
Cash at bank———————£3,842£8,936£35,640
Debtors———————£11,619£466£878
Liabilities
Creditors within one year£290,789£269,084£244,458£131,814£146,598—————
Creditors after one year£21,626£24,064£28,138£33,230£35,000—————
Net current assets−£223,930−£213,894−£212,920−£110,263−£110,605−£145,903−£63,748−£46,790−£17,741−£7,473
Assets less current liabilities−£222,350−£211,820−£210,188−£107,953−£109,450−£145,903−£63,748−£46,790−£17,741−£7,473
People
Average employees440323233—
Source evidenceView filing View filing View filing View filing View filing View filing View filing View filing View filing View filing

Secured borrowing

Registered charges, lenders and security interests.

Charges and related records

0 outstanding charges

No charges available in our records.